Press releases
2020
17 March, 2020
Guard Therapeutics International AB: Guard Therapeutics announces positive top line results from a clinical phase 1a study of ROSgard
2019
23 September, 2019
Redeye initiates coverage of A1M Pharma
We initiate coverage of A1M Pharma, a early stage biotech company developing a candidate to treat acute kidney injuries in associating with cardiac surgery. With a history of disappointment we now see real potential in A1M Pharma with their new management and strategy as they move towards meeting an unmet medical need. With a strong owner...